.RESEARCH EMPHASIZE.06 August 2024.
A large randomized controlled test along with cisgender females highlights the obstacles of faithfulness to an everyday dental preexposure prevention regiment and displays that twice-yearly treatment of lenacapavir can preserve effective HIV prevention levels over 6 months.